● Recruiting

A Study of LN-144 or LN-145 in People With Advanced Uveal Melanoma, Undifferentiated Pleomorphic Sarcoma, Dedifferentiated Liposarcoma, or Angiosarcoma

Condition: Uveal Melanoma · Melanoma · Metastatic Uveal Melanoma · Sponsor: Memorial Sloan Kettering Cancer Center

PhasePhase 1

Planned participants40

Who can joinAll sexes, 18 Years to no upper limit

Healthy volunteersNo

About this study

This is an open label study evaluating lifileucel (LN-144) in patients with metastatic uveal melanoma.

This description comes directly from the study's public registry record.

Talk to the study team

Lauren Banks, MD, PhD · 646-888-6784 · BanksL1@mskcc.org

James Smithy, MD, MHS · 646-888-6784 · smithyj@mskcc.org

Always discuss trial participation with your own doctor first.

Locations (2)

Memorial Sloan Kettering Westchester	Harrison, New York, United States	Recruiting
Memorial Sloan Kettering Cancer Center (All Protocol Activities)	New York, New York, United States	Recruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT05607095